by Christina | Jul 22, 2024 | Uncategorized
Greg Norden is the former Chief Financial Officer of Wyeth. Mr. Norden also serves on the Boards of Zoetis, the leading animal health company; Royalty Pharma, a leading funder of innovation across the biopharmaceutical industry; and Praxis, a clinical-stage...
by Christina | Jul 22, 2024 | Uncategorized
Paris Panayiotopoulos is a Senior Managing Director in the Blackstone Life Sciences group and a member of its Investment Committee, having joined Blackstone as part of its acquisition of Clarus in December 2018. Mr. Panayiotopoulos has over 20 years of...
by Christina | Jul 22, 2024 | Uncategorized
Richard C. Pasternak has spent the last 44 years as an academic and biopharmaceutical clinician-scientist. He is a retired Clinical Professor (Dept of Medicine) at the Weill Cornell Medical College and is a strategic consultant. He has served on multiple biotech and...
by Christina | Jul 22, 2024 | Uncategorized
Peter Renehan is a Principal on the Blackstone Life Sciences team. He was previously an investment banking Associate in Lazard’s San Francisco office, where he focused on biopharma mergers and acquisitions. His experience prior to Lazard includes working in corporate...
by Christina | Sep 27, 2024 | Uncategorized
Dr. Vasilisa (Vaska) Sazonov is the Head of the Cardiovascular-Renal-Metabolic (CRM) Commercial team at Novartis International (Basel, Switzerland) and an Observer to the Board of Directors at Anthos Therapeutics (Cambridge, MA, USA). Vaska brings over two decades of...
